The ASX has been trading flat at around 7,864 points.
Financials has been the best performing sector, up 0.3%, followed by Materials, up 0.15% and Energy, up 0.1%.
Utilities has been the worst performer, down 1.1%, followed by Industrials and Staples, both down 0.55%.
Opthea (ASX:OPT) has been the most watched on HotCopper forums today. The company is in a voluntary suspension pending the release of top line results of its COAST clinical trial.
Also trending Imugene (ASX:IMU) has revealed the US Food and Drug Administration has granted Fast Track Designation to its allogeneic CAR T-cell therapy, azer-cel (azercabtagene zapreleucel), for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
Rounding out the most discussed is Arizona Lithium (ASX:AZL) after kicking off a share purchase plan to raise $2 million to advance the Prairie project.
You’re up to date, see you later for market close.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。